Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
436.4 INR | +0.59% | +0.52% | +1.43% |
09:49am | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.43% | 2.8B | |
+31.79% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.23% | 239B | |
+9.94% | 210B | |
-7.20% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Jefferies Downgrades Laurus Labs to Underperform From Hold, Adjusts Price Target to INR250 From INR325